Evaluation of two yellow fever vaccines for routine immunization programs in Argentina

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Human Vaccines

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4161/hv.4.2.5216PMID 18382132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Yellow fever vaccine

  2017cited by this paper
• Shifting epidemiology of Flaviviridae.

  2008cited by this paper
• High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

  2007cited by this paper
• Early exposure to yellow fever vaccine during pregnancy

  2007cited by this paper
• 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.

  2007cited by this paper
• Out of Africa: A Molecular Perspective on the Introduction of Yellow Fever Virus into the Americas

  2007cited by this paper
• The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil.

  2006cited by this paper
• Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial.

  2005cited by this paper
• Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.

  2005cited by this paper
• Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.

  2005cited by this paper
• Current status of the Arilvax; yellow fever vaccine

  2004cited by this paper
• Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial.

  2004cited by this paper
• Variation in ragweed (Ambrosia artemisiifolia L.) pollen concentration in central Croatia, 2002-2003.

  2004cited by this paper
• Risk assessment of yellow fever urbanization in Rio de Janeiro, Brazil.

  2004cited by this paper
• Dengue and the risk of urban yellow fever reintroduction in São Paulo State, Brazil.

  2003cited by this paper
• Prevention of yellow fever in persons traveling to the tropics.

  2002cited by this paper
• Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

  2002cited by this paper
• Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.

  2001cited by this paper
• Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

  2001cited by this paper
• Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases.

  2001cited by this paper
• Hepatitis and death following vaccination with 17D-204 yellow fever vaccine.

  2001cited by this paper
• Current Status of Flavivirus Vaccines

  2001cited by this paper
• Resurgent vector-borne diseases as a global health problem.

  1998cited by this paper
• Reactogenicity of Yellow Fever Vaccines in a and Collaborative Group for the Study of Yellow Fever Vaccines*

  year unknowncited by this paper

• Electron transport chain capacity expands yellow fever vaccine immunogenicity

  2024influential citation
• National review of reported Yellow fever vaccine incidents in the UK.

  2022cites this paper
• 63 – Yellow Fever Vaccines

  2018cites this paper
• Early molecular correlates of adverse events following yellow fever vaccination.

  2017cites this paper
• Current status and future prospects of yellow fever vaccines

  2015cites this paper
• Yellow fever vaccine for patients with HIV infection.

  2014cites this paper
• Yellow fever vaccination: The potential of dose-sparing to increase vaccine supply and availability.

  2013cites this paper
• Safety of the yellow Fever vaccine: a retrospective study.

  2013cites this paper
• Safety profile of the yellow fever vaccine Stamaril®: a 17-year review

  2013cites this paper
• Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system.

  2009cites this paper